Vital Infrastructure Property Trust reported steady second-quarter operating results as it continued to simplify its international footprint, reduce costs and recycle capital into North American healthcare real estate.
Chief Executive Officer Zach Vaughan said the trust’s strategy centers on simplifying its footprint, strengthening its balance sheet, lowering its cost structure and maintaining disciplined capital allocation. During the quarter, Vital completed the remaining property sales in Europe under its larger transaction with TPG Real Estate, generating $145 million in net proceeds attributable to the REIT after transaction costs and taxes.
Portfolio Results and Cost Reductions
Same-property net operating income on a proportionate basis increased 2.3% year over year to $51 million in the second quarter, according to Chief Financial Officer Stephanie Karamarkovic. The increase reflected contractual rent escalations, rentalized capital expenditures, higher parking income and improved cost recoveries.
In North America, same-property NOI rose 1%, as rent escalations and parking income were largely offset by higher operating costs tied to the trust’s transition to outsourced facilities operations in November. Excluding that transition, North American same-property NOI increased 3.3%, while total portfolio same-property NOI would have risen 3.2%, management said.
Occupancy stood at 96.1% at quarter-end, while weighted average lease expiry exceeded 13 years. Vaughan said these metrics reflect the defensive characteristics and long-duration income associated with the healthcare-focused portfolio.
Funds from operations per unit, excluding accelerated amortization of financing costs, were $0.11, unchanged from the first quarter. Adjusted funds from operations per unit increased to $0.11 from $0.10 in the prior quarter. The trust’s AFFO payout ratio improved to 85% from 88% in the second quarter of the prior year.
General and administrative expense attributable to AFFO declined to $10 million from $12.2 million a year earlier. Karamarkovic attributed the reduction to the Vital Trust internalization, European portfolio sale, closure of four regional offices, outsourced Canadian facilities management and broader corporate cost initiatives.
Global headcount declined about 40% year over year, she said. Vital expects to reach an annualized G&A run rate of approximately $35 million by the end of 2026, excluding unit-based compensation and employee termination benefits. Karamarkovic said the full transition of European employees as of June 30 should have a meaningful effect on third-quarter costs.
Balance Sheet and Capital Deployment
Proportionate leverage improved to 46.8% at June 30, compared with 52.7% at the end of the first quarter and 56% a year earlier. Debt to adjusted EBITDA was 7.1 times, or about 7.7 times on a comparable basis excluding EBITDA from disposed European properties.
On a pro forma basis incorporating acquisitions and repayments after quarter-end, leverage would have been approximately 48.8% and debt to EBITDA would have been about eight times. Management said its medium- to long-term target is approximately 50% leverage or eight times debt to EBITDA.
Vital had more than $250 million of available liquidity as of the call date, including subsequent activities. The trust also refinanced AUD 715 million of Australian joint-venture term debt, equivalent to $210 million at Vital’s share, extending its maturity to December 2028 from December 2026.
The refinancing addressed the trust’s largest 2026 maturity, Karamarkovic said. She added that the refinancing involved an expanded group of lenders and indicated greater appetite for financing Australian healthcare assets.
Vital had expected to use European sale proceeds to repay its 6.25% Series H convertible debentures. However, management instead deployed capital toward North American investments it characterized as accretive. The debentures become callable without penalty on Sept. 1, subject to required notice, and the trust said it will evaluate asset sales, refinancing or a combination of approaches to address the maturity.
North American Acquisition Pipeline
Management said it has realized approximately $300 million of net proceeds over the past 12 months and recycled the capital into debt reduction and investments in North America.
- Vital committed to develop an ambulatory facility for RVH in Barrie, Ontario, expected to add $9 million in NOI, or $0.04 per unit, when completed in 2029.
- In March, the trust acquired a transitional-bed facility in Ottawa leased long term to The Ottawa Hospital.
- In July, Vital acquired a 142,000-square-foot integrated community health center in Brooklyn, New York, fully leased to AdvantageCare Physicians with approximately 11 years remaining on the lease and contractual annual rent escalations.
- The trust also signed a definitive agreement to acquire an outpatient property in Burlington, Ontario that is 99% leased to healthcare providers.
The Brooklyn and Burlington transactions total approximately $153 million, carry a going-in capitalization rate above 7%, and are expected to be immediately accretive, Vaughan said.
Vaughan said the acquisition pipeline is currently weighted about two-thirds toward the United States, where there are more healthcare acquisition opportunities because many Canadian healthcare assets are tied to single-payer systems. Development opportunities such as the RVH project are concentrated in Canada, he added.
Management is focusing U.S. acquisitions on outpatient assets, particularly in markets from the East Coast through the Southeast. Vaughan said all assets currently under consideration are expected to be accretive upon acquisition, rather than vacant buildings requiring repositioning.
Vital has targeted roughly $250 million of acquisitions for the full year and indicated that an additional $50 million of acquisitions before year-end would be a “safe assumption.” Management said potential funding sources for further investment could include the remaining European assets and its New Zealand holdings.
Development Optionality and Healthscope
In July, Vital received City of Toronto rezoning approval for Fairview Health Centre. The approval allows for up to 980,000 square feet of buildable area, including 100,000 square feet of medical space, with the remaining area eligible for market-rate residential development without an affordable-housing requirement.
Vaughan said the trust is discussing healthcare needs with potential larger community health operators in the area. After determining the health component of the project, Vital may sell excess land or partner with another party to lead residential development, he said.
In Australia, management said a consortium of four operators is conducting diligence with the receiver on the acquisition of Healthscope’s remaining assets and operating business. Vital supports the consortium, along with another major landlord, Vaughan said.
Vital has a committed transaction with Calvary, an Australian not-for-profit hospital and senior-housing operator, to enter into new leases for all 12 of its Healthscope properties, subject to lender and receiver approvals. Karamarkovic said the trust could not yet disclose specific lease terms or any potential rent concessions because the transaction remains subject to approval.
Vaughan said hospital operating performance in Australia continues to improve, while institutional capital has begun returning to the market. He cited a recent sale of a suburban Melbourne hospital for AUD 291 million at a capitalization rate in the low-5% range as an encouraging indicator for market liquidity and values.
Management said it expects Vital to be materially simpler over the next 12 months and largely North America-focused over approximately 24 months, though the timing will depend on assets and partnerships outside the region.
About NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN)
Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.
